cetraxate has been researched along with Helicobacter Infections in 6 studies
Helicobacter Infections: Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| " pylori) infection is known to affect the gastric microcirculation, and cetraxate is reported to accelerate gastric ulcer healing, possibly by augmenting gastric mucosal blood flow (MBF)." | 5.09 | Influence of Helicobacter pylori infection and cetraxate on gastric mucosal blood flow during healing of endoscopic mucosal resection-induced ulcers. ( Adachi, K; Fujishiro, H; Ishihara, S; Kawamura, A; Kazumori, H; Kinoshita, Y; Moriyama, N; Okuyama, T; Sato, H; Suetsugu, H; Watanabe, M, 2001) |
| "Cetraxate is an anti-ulcer drug that increases gastric mucosal blood flow." | 2.69 | Cetraxate, a mucosal protective agent, combined with omeprazole, amoxycillin, and clarithromycin increases the eradication rate of helicobacter pylori in smokers. ( Haruma, K; Hattori, N; Kajiyama, G; Kamada, T; Kawamura, Y; Kitadai, Y; Mihara, M; Miyoshi, E; Mukai, T; Sumii, K; Tahara, K; Yoshihara, M, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, CJ | 1 |
| Hsu, PI | 1 |
| Lo, GH | 1 |
| Lo, CC | 1 |
| Lin, CK | 1 |
| Shie, CB | 1 |
| Peng, NJ | 1 |
| Tseng, HH | 1 |
| Jou, HS | 1 |
| Tsai, PM | 1 |
| Chen, A | 1 |
| Chen, JL | 1 |
| Lai, KH | 1 |
| Kubota, K | 2 |
| Shimizu, N | 2 |
| Nozaki, K | 1 |
| Takeshita, Y | 1 |
| Ueda, T | 1 |
| Imamura, K | 1 |
| Hiki, N | 1 |
| Yamaguchi, H | 1 |
| Shimoyama, S | 1 |
| MaFune, K | 1 |
| Kaminishi, M | 2 |
| Oka, M | 1 |
| Ichinose, M | 1 |
| Fujishiro, M | 1 |
| Omata, M | 1 |
| Kamada, T | 1 |
| Haruma, K | 1 |
| Miyoshi, E | 1 |
| Mihara, M | 1 |
| Kitadai, Y | 1 |
| Yoshihara, M | 1 |
| Sumii, K | 1 |
| Kajiyama, G | 1 |
| Tahara, K | 1 |
| Mukai, T | 1 |
| Kawamura, Y | 1 |
| Hattori, N | 1 |
| Adachi, K | 1 |
| Suetsugu, H | 1 |
| Moriyama, N | 1 |
| Kazumori, H | 1 |
| Kawamura, A | 1 |
| Fujishiro, H | 1 |
| Sato, H | 1 |
| Okuyama, T | 1 |
| Ishihara, S | 1 |
| Watanabe, M | 1 |
| Kinoshita, Y | 1 |
1 review available for cetraxate and Helicobacter Infections
| Article | Year |
|---|---|
[Eradication therapy for the remnant stomach infected with Helicobacter pylori ].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; En | 2005 |
5 trials available for cetraxate and Helicobacter Infections
| Article | Year |
|---|---|
Comparison of cetraxate-based and pantoprazole-based triple therapies in the treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer | 2004 |
Efficacy of triple therapy plus cetraxate for the Helicobacter pylori eradication in partial gastrectomy patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Infective Agents; Anti-Ulcer Agents; Drug | 2005 |
[Cetraxate hydrochloride (Neuer) induces the effectiveness of new triple therapy in H. pylori eradication].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clar | 2005 |
Cetraxate, a mucosal protective agent, combined with omeprazole, amoxycillin, and clarithromycin increases the eradication rate of helicobacter pylori in smokers.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Met | 2000 |
Influence of Helicobacter pylori infection and cetraxate on gastric mucosal blood flow during healing of endoscopic mucosal resection-induced ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Anti-Ulcer Agents; Female; Gastric | 2001 |